185 related articles for article (PubMed ID: 16878999)
1. The treatment of type 2 diabetes mellitus in youth : which therapies?
Miller JL; Silverstein JH
Treat Endocrinol; 2006; 5(4):201-10. PubMed ID: 16878999
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.
; Zeitler P; Epstein L; Grey M; Hirst K; Kaufman F; Tamborlane W; Wilfley D
Pediatr Diabetes; 2007 Apr; 8(2):74-87. PubMed ID: 17448130
[TBL] [Abstract][Full Text] [Related]
3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
4. Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management.
Brown A; Desai M; Taneja D; Tannock LR
Postgrad Med; 2010 Jan; 122(1):163-71. PubMed ID: 20107300
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
6. The management of type 2 diabetes mellitus in children and adolescents.
Miller JL; Silverstein JH
J Pediatr Endocrinol Metab; 2005 Feb; 18(2):111-23. PubMed ID: 15751600
[TBL] [Abstract][Full Text] [Related]
7. Treatment of 'Diabesity': Beyond Pharmacotherapy.
Singh H; Venkatesan V
Curr Drug Targets; 2018; 19(14):1672-1682. PubMed ID: 29929463
[TBL] [Abstract][Full Text] [Related]
8. Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy: Metformin, Alpha-Glucosidase Inhibitors, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors.
DeGeeter M; Williamson B
J Pharm Pract; 2016 Apr; 29(2):144-59. PubMed ID: 25312263
[TBL] [Abstract][Full Text] [Related]
9. The effects of pharmacologic agents for type 2 diabetes mellitus on body weight.
Pi-Sunyer FX
Postgrad Med; 2008 Jul; 120(2):5-17. PubMed ID: 18654064
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitisation in the treatment of Type 2 diabetes.
Tadayyon M; Smith SA
Expert Opin Investig Drugs; 2003 Mar; 12(3):307-24. PubMed ID: 12605557
[TBL] [Abstract][Full Text] [Related]
11. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
Nadeau DA
Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512
[TBL] [Abstract][Full Text] [Related]
12. Clinical decisions. Management of type 2 diabetes.
Goldberg RB; Holman R; Drucker DJ
N Engl J Med; 2008 Jan; 358(3):293-7. PubMed ID: 18199869
[No Abstract] [Full Text] [Related]
13. [Drug treatment of type 2 diabetes].
Tielmans A; Laloi-Michelin M; Coupaye M; Virally M; Meas T; Guillausseau PJ
Presse Med; 2007 Feb; 36(2 Pt 2):269-78. PubMed ID: 17258675
[TBL] [Abstract][Full Text] [Related]
14. [Effects of anti-diabetic therapy on overweight/obesity and dyslipidemia: traditional hypoglycemic agents (metformin, sulfonylureas, thiazolidinediones) versus glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors].
Fiorentino TV; Sesti G
G Ital Cardiol (Rome); 2013 Dec; 14(12 Suppl):15-25. PubMed ID: 24362783
[TBL] [Abstract][Full Text] [Related]
15. Beyond glycemic control: treating the entire type 2 diabetes disorder.
Brunton S
Postgrad Med; 2009 Sep; 121(5):68-81. PubMed ID: 19820276
[TBL] [Abstract][Full Text] [Related]
16. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
17. Which oral agent to use when metformin is no longer effective?
Bannon M
QJM; 2011 Mar; 104(3):183-4. PubMed ID: 21330402
[No Abstract] [Full Text] [Related]
18. Approach to the Patient: Youth-Onset Type 2 Diabetes.
Hitt TA; Hannon TS; Magge SN
J Clin Endocrinol Metab; 2023 Dec; 109(1):245-255. PubMed ID: 37584397
[TBL] [Abstract][Full Text] [Related]
19. What to add in with metformin in type 2 diabetes?
Petrie JR; Adler A; Vella S
QJM; 2011 Mar; 104(3):185-92. PubMed ID: 21156663
[TBL] [Abstract][Full Text] [Related]
20. Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
Purnell JQ; Weyer C
Treat Endocrinol; 2003; 2(1):33-47. PubMed ID: 15871553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
